HIGHLIGHTS
- who: Nina Wilkinson from the Institute of Health and Society, Faculty of Medical Sciences, UK have published the article: Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study, in the Journal: (JOURNAL) of 28/06/2018
- what: The authors explore the relationship between drug levels and treatment response, accounting for individual patient characteristics to determine (i) the adalimumab therapeutic range (i.e., both the minimal effective drug level and the drug level beyond which response plateaus) and_(ii) whether drug level predicts longer-term response. The authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.